MX2007005124A - Composiciones farmaceuticas espontaneamente dispersables. - Google Patents

Composiciones farmaceuticas espontaneamente dispersables.

Info

Publication number
MX2007005124A
MX2007005124A MX2007005124A MX2007005124A MX2007005124A MX 2007005124 A MX2007005124 A MX 2007005124A MX 2007005124 A MX2007005124 A MX 2007005124A MX 2007005124 A MX2007005124 A MX 2007005124A MX 2007005124 A MX2007005124 A MX 2007005124A
Authority
MX
Mexico
Prior art keywords
pharmaceutical compositions
dispersible pharmaceutical
spontaneously dispersible
solid
room temperature
Prior art date
Application number
MX2007005124A
Other languages
English (en)
Spanish (es)
Inventor
Madhusudhan Pudipeddi
Alan Edward Royce
Ping Li
Abu T M Serajuddin
Barbara Luckel
Sara Royce Hynes
Michael Ambuhl
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of MX2007005124A publication Critical patent/MX2007005124A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dispersion Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MX2007005124A 2004-10-29 2005-10-27 Composiciones farmaceuticas espontaneamente dispersables. MX2007005124A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US62334504P 2004-10-29 2004-10-29
US62334404P 2004-10-29 2004-10-29
PCT/US2005/039004 WO2006050123A1 (en) 2004-10-29 2005-10-27 Spontaneously dispersible pharmaceutical compositions

Publications (1)

Publication Number Publication Date
MX2007005124A true MX2007005124A (es) 2007-06-22

Family

ID=35876536

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2007005124A MX2007005124A (es) 2004-10-29 2005-10-27 Composiciones farmaceuticas espontaneamente dispersables.

Country Status (9)

Country Link
US (1) US20080064760A1 (enExample)
EP (1) EP1807049A1 (enExample)
JP (1) JP2008518931A (enExample)
KR (1) KR20070069172A (enExample)
AU (1) AU2005302501A1 (enExample)
BR (1) BRPI0518239A2 (enExample)
CA (1) CA2578854A1 (enExample)
MX (1) MX2007005124A (enExample)
WO (1) WO2006050123A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2663558C (en) * 2006-09-26 2013-05-28 Samyang Corporation Submicron nanoparticle of poorly water soluble camptothecin derivatives and process for preparation thereof
MX2009005947A (es) * 2006-12-05 2009-06-17 Novartis Ag Formas de dosificacion en microemulsion de valsartan, y metodos para elaborarlas.
WO2008092084A2 (en) 2007-01-26 2008-07-31 Centocor, Inc. Injectable non-aqueous suspension with high concentration of therapeutic agent
SG10201503234SA (en) 2010-05-03 2015-06-29 Teikoku Pharma Usa Inc Non-Aqueous Taxane Pro-Emulsion Formulations and Methods of Making and Using the Same
JO3685B1 (ar) 2012-10-01 2020-08-27 Teikoku Pharma Usa Inc صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU215966B (hu) * 1994-11-21 1999-07-28 BIOGAL Gyógyszergyár Rt. Orálisan alkalmazható, ciklosporint tartalmazó, összetett emulzió-előkoncentrátum
CA2284000C (en) * 1997-03-12 2012-01-03 Abbott Laboratories Hydrophilic binary systems for the administration of cyclosporine
ID25908A (id) * 1998-03-06 2000-11-09 Novartis Ag Prakonsentrat-prakonsentrat emulsi yang mengandung siklosporin atau makrolida
US20020102301A1 (en) * 2000-01-13 2002-08-01 Joseph Schwarz Pharmaceutical solid self-emulsifying composition for sustained delivery of biologically active compounds and the process for preparation thereof
US6828301B2 (en) * 2002-02-07 2004-12-07 Boehringer Ingelheim International Gmbh Pharmaceutical compositions for hepatitis C viral protease inhibitors
WO2004047673A2 (en) * 2002-11-21 2004-06-10 Novacea, Inc. Treatment of liver disease with active vitamin d compounds

Also Published As

Publication number Publication date
AU2005302501A1 (en) 2006-05-11
JP2008518931A (ja) 2008-06-05
CA2578854A1 (en) 2006-05-11
EP1807049A1 (en) 2007-07-18
US20080064760A1 (en) 2008-03-13
BRPI0518239A2 (pt) 2008-11-11
KR20070069172A (ko) 2007-07-02
WO2006050123A1 (en) 2006-05-11

Similar Documents

Publication Publication Date Title
WO2001076561A3 (en) Pharmaceutical compositions
EP2269631A3 (en) Pharmaceutical compositions comprising botulinum neurotoxin for use in medicine and cosmetics
WO2002067902A3 (en) Modulation of release from dry powder formulations
NO20025621D0 (no) Farmasöytisk sammensetning med vedvarende frigjöring for parenteral administrasjon av hydrofile forbindelser
DK1083884T3 (da) Fremgangsmåde til stabilisering af polyvinylpyrrolidonsammensætninger
WO2008067164A3 (en) Solid pharmaceutical dosage formulations
DK1183014T3 (da) Smagsmaskerede orale farmaceutiske sammensætninger med kontrolleret frigivelse
NO20064094L (no) Partikler
TW200621268A (en) Antimicrobial copolymers and uses thereof
WO2001091725A3 (en) Biologically useful polyphosphates
BR0215380A (pt) Pó micronizado farmacêutico ou nutracêutico de liberação imediata e utilização do mesmo
PT1401501E (pt) Composicoes farmaceuticas orais com libertacao modificada do ingrediente activo
PL1663216T3 (pl) Kompozycje o zmodyfikowanym uwalnianiu zawierające takrolimus
EP1790340A3 (en) Combination chemotherapy
WO2002089773A3 (en) Pharmaceutical compositions comprising cyclosporin
ATE293995T1 (de) Pharmazeutische zusammensetzungen, die wirkstoffabsorptionsfördernde verbindungen enthalten
WO2003000226A3 (en) Pharmaceutical compositions containing polymer and drug assemblies
EP1708719A4 (en) AQUEOUS PHARMACEUTICAL COMPOSITIONS OF 2,6-DIISOPROPYLPHENOL (PROPOFOL) AND THEIR USE
WO2008085556A3 (en) Surfactant-free nanoparticles for drug delivery
DE602005008589D1 (de) Biologisch abbaubare pfropfcopolymere
WO2007100382A3 (en) Orally administrable gallium compositions and method of use
MX2007005124A (es) Composiciones farmaceuticas espontaneamente dispersables.
IL171875A0 (en) Pioglitazone salts,such as pioglitazone sulfate, and pharmaceutical compositions and processes using the same
NO20076120L (no) Stabile nanopartikkelformuleringer
BR0206960A (pt) Composição farmacêutica oral, e, uso de um polìmero de ftalato de hidroxipropilmetilcelulose

Legal Events

Date Code Title Description
FA Abandonment or withdrawal